F.D.A. Decisions on Abortion Pill Were Based on Science, New Analysis Finds
PositiveScience

- A recent analysis of over 5,000 pages of FDA documents regarding mifepristone, the abortion pill, indicates that FDA leaders consistently adhered to evidence-based recommendations from scientists over a 12-year period. This finding underscores the agency's commitment to scientific integrity in its decision-making processes.
- The implications of this analysis are significant for the FDA, as it reinforces the credibility of its decisions regarding mifepristone amidst ongoing scrutiny and debate about the pill's safety and efficacy.
- This development highlights a broader tension in the scientific community regarding regulatory oversight, particularly in light of past political influences that have raised concerns about the integrity of scientific evaluations and the potential impact on public health policies.
— via World Pulse Now AI Editorial System

